Award recordCONTRACT

AMERICAN NATIONAL RED CROSS, THE

PIID VA24816C0100· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· Q301 · MEDICAL- LABORATORY TESTING· FY2016· $1,922,421 net obligations· UEI G69LHXJ3ABL5· DC

Description

CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS

First action · last action
2016-05-01 · 2018-11-14
Transactions
12
First transaction's obligation
$625,000
Base + all options value (sum of deltas)
$1,922,421
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS

Modification chain · 12 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$2,189,302$0Base award · 2016-05-01 · this action $625,000 · running total $625,000Modification P00001 · 2016-09-13 · this action -$141,867 · running total $483,133Modification P00002 · 2016-10-01 · this action $875,000 · running total $1,358,133Modification P00003 · 2017-02-13 · this action -$20,702 · running total $1,337,431Modification P00004 · 2017-05-01 · this action $625,000 · running total $1,962,431Modification P00005 · 2017-06-12 · this action -$398,129 · running total $1,564,302Modification P00006 · 2017-07-06 · this action -$250,000 · running total $1,314,302Modification P00007 · 2017-10-01 · this action $875,000 · running total $2,189,302Modification P00008 · 2017-10-30 · this action -$81,483 · running total $2,107,819Modification P00009 · 2018-04-02 · this action $0 · running total $2,107,819Modification P00010 · 2018-08-27 · this action -$188,720 · running total $1,919,099Modification P00011 · 2018-11-14 · this action $3,322 · running total $1,922,421
  • Base2016-05-01+$625,000= $625,000
  • Mod P000012016-09-13-$141,867= $483,133
  • Mod P000022016-10-01+$875,000= $1,358,133
  • Mod P000032017-02-13-$20,702= $1,337,431
  • Mod P000042017-05-01+$625,000= $1,962,431
  • Mod P000052017-06-12-$398,129= $1,564,302
  • Mod P000062017-07-06-$250,000= $1,314,302
  • Mod P000072017-10-01+$875,000= $2,189,302
  • Mod P000082017-10-30-$81,483= $2,107,819
  • Mod P000092018-04-02+$0= $2,107,819
  • Mod P000102018-08-27-$188,720= $1,919,099
  • Mod P000112018-11-14+$3,322= $1,922,421
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-05-01+$625,000$625,000CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00001· FUNDING ONLY ACTION2016-09-13−$141,867$483,133CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00002· FUNDING ONLY ACTION2016-10-01+$875,000$1,358,133CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00003· FUNDING ONLY ACTION2017-02-13−$20,702$1,337,431CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00004· FUNDING ONLY ACTION2017-05-01+$625,000$1,962,431CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00005· FUNDING ONLY ACTION2017-06-12−$398,129$1,564,302CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00006· FUNDING ONLY ACTION2017-07-06−$250,000$1,314,302CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00007· FUNDING ONLY ACTION2017-10-01+$875,000$2,189,302CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00008· FUNDING ONLY ACTION2017-10-30−$81,483$2,107,819CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00009· FUNDING ONLY ACTION2018-04-02+$0$2,107,819CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00010· FUNDING ONLY ACTION2018-08-27−$188,720$1,919,099CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS
Mod P00011· FUNDING ONLY ACTION2018-11-14+$3,322$1,922,421CLOSELY ASSOCIATED IGF::CL::IGF BLOOD AND BLOOD COMPONENTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI G69LHXJ3ABL5)

AwardOffice · PSC / listingNet obligationsFY
36C25226N0550252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$2,500FY2026
36C25226N0551252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$2,100FY2026
36C25226N0549252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$170FY2026
36C25226N0548252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$10,000FY2026
36C25026P0816250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$19,329FY2026
36C24126N0603241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$1,998,719FY2026

Other recipients under Q301 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826N0684VERACYTE, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$49,730FY2026
36C24826P0831UNIVERSITY OF MIAMI248-NETWORK CONTRACT OFFICE 8 (36C248)$178,265FY2026
36C24826N0548D & D LABORATORY LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$14,915FY2026
36C24826P0651ROCHE DIAGNOSTICS CORPORATION248-NETWORK CONTRACT OFFICE 8 (36C248)$239,858FY2026
36C24826P0221REPROSOURCE FERTILITY DIAGNOSTICS, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$27,500FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24816C0100_3600_-NONE-_-NONE- · retrieved 2026-09-26.